Cellectar BioSciences Inc. buy Roth Capital
Start price
14.08.25
/
50%
€0.26
Target price
14.08.26
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 14.08.26. The prediction end date can be changed by Roth_Capital at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cellectar BioSciences Inc. | - | - |
| iShares Core DAX® | 1.644% | 4.865% |
| iShares Nasdaq 100 | 0.747% | 2.923% |
| iShares Nikkei 225® | 2.442% | 6.212% |
| iShares S&P 500 | 0.618% | 2.843% |
Comments by Roth_Capital for this prediction
In the thread Cellectar BioSciences Inc. diskutieren
Cellectar Biosciences, Inc. (NASDAQ: CLRB) had its "buy" rating re-affirmed by analysts at Roth Capital.
Ratings data for CLRB provided by MarketBeat